PS
LKFT

Principal Securities’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Principal Securities’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-184
Closed -$6.37K – 2224
2025
Q3 		$6.37K Sell
184
-2
-1% -$64 ﹤0.01% 2882
2025
Q2 		$5.21K Buy
186
+58
+45% +$1.55K ﹤0.01% 2854
2025
Q1 		$3.52K Hold
128
– – ﹤0.01% 2895
2024
Q4 		$3.52K Buy
128
+22
+21% +$613 ﹤0.01% 2891
2024
Q3 		$3.05K Buy
106
+39
+58% +$1.06K ﹤0.01% 2827
2024
Q2 		$1.66K Buy
67
+19
+40% +$539 ﹤0.01% 2960
2024
Q1 		$1.55K Buy
+48
New +$1.78K ﹤0.01% 2937

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Principal Securities's LKFT Position: Q4 2025 in Review

Principal Securities sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2025, closing a stake of 184 shares — an estimated $6.37K sold.

Principal Securities first reported a position in LKFT in Q1 2024 and held it in 7 quarters. The position peaked at $6.37K in Q3 2025. 90 funds tracked by Wall St. Rank hold LKFT as of Q4 2025.

  • Principal Securities reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 184 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2025, an estimated $6.37K.
  • Principal Securities first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2024 and held it in 7 quarters.
  • Principal Securities's Lakefront Biotherapeutics American Depositary Shares position peaked at $6.37K in Q3 2025.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.